carmustine has been researched along with Amyloidosis in 3 studies
Carmustine: A cell-cycle phase nonspecific alkylating antineoplastic agent. It is used in the treatment of brain tumors and various other malignant neoplasms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p462) This substance may reasonably be anticipated to be a carcinogen according to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (From Merck Index, 11th ed)
carmustine : A member of the class of N-nitrosoureas that is 1,3-bis(2-chloroethyl)urea in which one of the nitrogens is substituted by a nitroso group.
Amyloidosis: A group of sporadic, familial and/or inherited, degenerative, and infectious disease processes, linked by the common theme of abnormal protein folding and deposition of AMYLOID. As the amyloid deposits enlarge they displace normal tissue structures, causing disruption of function. Various signs and symptoms depend on the location and size of the deposits.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Therapy with multiple alkylating agents did not result in a higher response rate or longer survival time, compared with standard melphalan and prednisone treatment in patients with primary systemic amyloidosis." | 9.09 | Prospective randomized trial of melphalan and prednisone versus vincristine, carmustine, melphalan, cyclophosphamide, and prednisone in the treatment of primary systemic amyloidosis. ( Gertz, MA; Greipp, PR; Kyle, RA; Lacy, MQ; Lust, JA; Witzig, TE, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mahendra, P | 1 |
| Johnson, D | 1 |
| Scott, MA | 1 |
| Jestice, HK | 1 |
| Hood, IM | 1 |
| Ager, S | 1 |
| Bass, G | 1 |
| Barker, P | 1 |
| Boraks, PA | 1 |
| Bloxham, DM | 1 |
| Baglin, TP | 1 |
| Marcus, RE | 1 |
| Gertz, MA | 2 |
| Lacy, MQ | 2 |
| Dispenzieri, A | 1 |
| Lust, JA | 1 |
| Greipp, PR | 1 |
| Witzig, TE | 1 |
| Kyle, RA | 1 |
1 review available for carmustine and Amyloidosis
| Article | Year |
|---|---|
Peripheral blood progenitor cell transplantation: a single centre experience comparing two mobilisation regimens in 67 patients.
Topics: Adolescent; Adult; Amyloidosis; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carmust | 1996 |
2 trials available for carmustine and Amyloidosis
| Article | Year |
|---|---|
Peripheral blood progenitor cell transplantation: a single centre experience comparing two mobilisation regimens in 67 patients.
Topics: Adolescent; Adult; Amyloidosis; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carmust | 1996 |
Prospective randomized trial of melphalan and prednisone versus vincristine, carmustine, melphalan, cyclophosphamide, and prednisone in the treatment of primary systemic amyloidosis.
Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Amyloidosis; Carmustine; Cyclophosphamide; Drug T | 1999 |
1 other study available for carmustine and Amyloidosis
| Article | Year |
|---|---|
Amyloidosis: recognition, confirmation, prognosis, and therapy.
Topics: Aged; Amyloidosis; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosphamide; Dia | 1999 |